Skip to main content
Premium Trial:

Request an Annual Quote

Axon Settles Oxford Gene Technology Suit

NEW YORK, June 18 - Axon Instruments, the Union City, Calif.-based maker of scanners widely used in microarray-based genomic research, announced today that it has reached a settlement in a patent infringement lawsuit filed by UK-based Oxford Gene Technology in December.


In a statement, the company said that it will provide undisclosed labeling on its genomic products. Financial terms of the settlement were not disclosed.


In December, OGT, filed two lawsuits in US District Court in Wilmington, Del., against a wide array of companies in the microarray field. OGT is an Oxford, UK-based company created in 1995 to license and manage the patents created in the labs of microarray pioneer Edwin Southern of Oxford University

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.